




POLICY AND PRACTICE UPDATES 
 
深圳“新医改”启动：挑战药品招标采购 


















Shen Zhen Initiates “New Healthcare Reform”: Challenging Current Medicine Procurement System 
 
In May, City of Shen Zhen in Guangdong Province introduced the Reform Implementation Plan for 
Separation of Hospital Management and Medicine Procurement in Public Hospitals, formally 
initiating the reform, eliminating public hospital medicine markups by the end of 2012, allowing 
patients to use medicine outside the hospital system, and improving current public hospital 
reimbursement system.  
 
In order to reduce hospital revenue shortfalls resulting from zero medicine markups, Shen Zhen will 
increase hospital fees and decrease medicine purchasing price through group procurement. Shen 
Zhen Public Hospital Management Office will compile a medicine list based on Guangdong 
Province Unified Procurement Bidding List and Price, and represent all public hospitals in the city to 
negotiate with medicine suppliers to reach lowest possible price. The management office will also 
attempt to establish a direct link between pilot hospitals and medicine suppliers, eliminating all 


































Poisonous medicine capsule follow-up: Food and Drug Ministry Strengthening Management of 
Pharmaceutical Excipients   
 
State Food and Drug Administration recently announced “Provisions Relating to Strengthening 
Management and Monitoring of Pharmaceutical Excipients (Draft Version for Comment)” (refer to 
as the Draft from this point on). Pharmaceutical excipients refer to excipients and additives needed 
for production of medicine, such as sugar, starch, film-coating powder, and the gelatin capsules 
that recently shocked the entire country. The Draft was put together in response to these gelatin 
capsules with high levels of Chromium, which exposed loopholes in the current pharmaceutical 
excipients management system.  
 
The Draft proposed several interventions (e.g., detailed information registration, extended 
inspection, and increased fine for violators) and made corresponding provisions for 
pharmaceutical companies, pharmaceutical excipients companies, and regulatory agencies.  
 
Pharmaceutical companies must improve quality assessment of the purchased excipients, by 
periodically inspect excipient production companies and establish a database for excipients used 
and excipients providers. Pharmaceutical excipient companies must meet a higher quality 
threshold to be permitted production. Different types of excipients should be managed separately 
based on their levels of risk. In the future, national and provincial governments will set up databases 
to better monitor excipients and their productions.  
 
The commenting period was proposed to end by June 8th, and the Draft was expected to go into 






早在 2011 年 1 月胡锦涛访美时就公布的中美公私医疗伙伴关系初步框架，终于有了实质性进展。2012 年 6 月
26 日，中国美国商会与中国卫生部相关机构签署协议，启动县级医院慢性病管理培训试点项目，为 50 所县级
























New Movement in China-America Health Diplomacy 
Source: CaiJing Magazine, 2012-07-01 
http://magazine.caijing.com.cn/2012-07-01/111921729.html 
 
The Chinese-American Public Private Healthcare Partnership that was initially established during 
President Jintao Hu’s visit to the U.S. in January 2011 saw substantive developments recently. On 
June 26 of 2012, Chinese and American Chambers of Commerce signed agreement with the 
Chinese Ministry of Health and its related agencies, putting in motion a county-level pilot program 
training 1000 doctors for 50 county-level hospitals in the management of chronicle diseases.  
 
In a public private partnership, public and private sectors establish long-term partnership to bring 
services to the general population. In this particular case, the initial framework was jointly drafted 
by Chinese (Ministry of Health, Ministry of Commerce) and American (Trade and Development 
Agency, Department of Health and Human Services, Department of Commerce) government 
agencies. In addition, eighteen businesses including Johnson & Johnson, IBM, General Electric, five 
non-government organizations, and one medical research facility also participated in the process. 
For the first time in medical health field, China and America moved from government-centric 
diplomacy to public diplomacy involving multiple partners from private, non-government, and 
research sectors. 
 







品种最多可能达到 700 种，超出原来 500 种的市场预期。 
 
中国证券报记者了解到，部分毛利率较高的抗肿瘤、血液制品药物将大幅降价，但血液制品药物中的紧缺品种
或不受影响。免疫调节类药物中，可能有部分药物面临降价。这将是近 14 年来第 30 次药品降价，部分药品降

















New Round of Drug Price Reduction in the Pipeline: Reduction May Exceed 20% 
 
National Development and Reform Commission will soon announce a new round of drug price 
reduction. This time the reduction may exceed 20% and include cancer treatment drugs and blood 
products. Sources in the Ministry of Health revealed that the national basic drug list is being revised 
to better reflect the needs of second and third tier hospitals. The list is also expanding to include 
nearly 700 types of drugs, exceeding the expected 500 types.  
 
Even after 30 price adjustments in 14 years, and 2 reductions this year alone, drug prices are still 
viewed as artificially high. Currently, the main factors behind the most recent price reductions are 
the implementation of “Separation of Medical Treatment and Drug Prescription” and abolishment 
of drug markup. These policies have been piloted in Beijing, Shanghai, Shenzhen, and others.  
 
It is too early to judge how this round of price reduction will impact pharmaceutical companies; the 
huge markups on drug prices might cushion any negative consequences. However, according to 
Zhu Chen, the Minister of Health, regulation of drug distribution is inevitable, with current reforms 































Commercial Insurance Companies Involved in Catastrophic Health Insurance   
 
After piloting in various cities and regions, several ministries co-signed related documents to push for 
national commercialization of catastrophic health insurance. The document “Guidance regarding 
Implementation of Catastrophic Health Insurance for Urban and Rural Residents” (Referred to as 
“Guidance” from now on) focuses on people insured under the New Rural Cooperative Medical 
Insurance and Urban Residents Insurance. These insurance plans, unlike the Urban Workers Medical 
Insurance, did not cover serious illnesses, resulting in low reimbursement and high cost for the 
insured.  
 
The Guidance was reviewed during the eleventh Plenary Session for the State Council Leading 
Group for Deepening the Health Care System Reform, on July 19, 2012. According to Keqiang Li, 
the Vice Premier of State Council and lead for this Leading Group, catastrophic health insurance is 
an important standard to judge whether a nation offers adequate medical care for its citizens. 
Currently, basic medical insurance is available nation-wide. However, most citizens still pay high 
prices for medical care because there is very limited catastrophic health insurance.  
 
Experts believe this policy will maximize the utilization of commercial insurance companies’ 























China Implements New Policy for Catastrophic Health Insurance: Reimbursement to Exceed 50% 
 
On August 30, National Development and Reform Commission, Ministry of Health, Ministry of 
Finance, Ministry of Human Resources and Social Security, Ministry of Civil Affairs, and Insurance 
Regulatory Commission announced the “Guidance regarding Implementation of Catastrophic 
Health Insurance for Urban and Rural Residents” (Referred to as “Guidance” from now on).  
 
“Guidance” indicated that even though citizens have basic medical insurance, they still bear 
heavy financial burden for medical care because serious illnesses were not covered under the New 




to alleviate this burden and to stop the vicious cycle of “poor because getting ill, getting ill 
because poor”.  
 
This new benefit will be financed by the funds for the two above-mentioned insurance plans, at no 
additional cost to the insured. If the insured suffers a serious illness, their out-of-pocket costs will be 
off-set by this new benefit. Reimbursement rate cannot be lower than 50%; the higher the medical 
cost, the higher the reimbursement rate.  
 
“Guidance” indicated that the commercial insurance institute undertaking this new benefit will be 
selected through public bidding. Qualified insurance institutes will voluntarily participate in this 
bidding, and assume sole responsibility for profits or losses. Under current regulations, profit from 
































Minister of Health, Zhu Chen: Welcome Private and Foreign Capital  
 
Zhu Chen, the Minister of Health, at the Summer Davos Forum in Tianjin, reiterated that Chinese 
health industries welcome both private and foreign investments.  
 
“China has an open economic market, also an open health industry policy. Chinese health industry 






China’s health industry has been undergoing dramatic changes in the past decades. With 
increased healthcare coverage and improved level of protection, there is exponential growth in 
demand for healthcare services. This appetite for healthcare services also led to development of 
traditional health industries such as biomedical and medical insurance industry. China’s economic 
development and changes in population structure also led to diversified medical services, with 
growth in areas such as old age care and medical tourism.  
 
Public medical institutes still occupy majority of medical care, but increasingly couldn’t meet the 
growing demand. The New Medical Reform encourages the introduction of social capital, but 
results are mixed. In order to change the status quo, the Reform adopted “Promote One, Suppress 
One” approach: 20% of the medical system development is reserved for social capital, and public 
hospitals are prohibited from using loans for needless expansion.  
 
Zhu Chen believes that Chinese health industries not only need high-end medical services, but also 
high-quality and low-cost medical products with wide coverage. These products will be very 
profitable, and investments from foreign companies are welcome. 
 
大病保险“引擎效应”可期 年新增保费 400 亿 




50%的保障目标，2011 年人均需要筹资 45 元，对保险行业而言，相当于每年要新增 400 多亿元的保障险业务市










Catastrophic Health Insurance: Expected Annual Additional Premium Revenue around ¥40 Billion 
 
Deputy Director for the Medical Reform Office of the State Council, Shanchang Xu, described the 
scale and volume to be expected from the new Guidance on catastrophic health insurance for 
rural and urban residents.  
 
“Catastrophic health insurance involves around one billion urban and rural residents in China. 
According to our research, using 100 million residents as the basis for our projection, in order to 
reach 50% coverage, each person needs to spend ¥45 in 2011. For insurance companies, this 
equals to annual new revenue around ¥40 billion, and this number will increase with economic 
development.” 
 
Chairman of the Insurance Regulatory Commission, Junbo Xian, also emphasized the challenges 
and risks facing the participating insurance companies. Sub-bar implementation of this new benefit 
could potentially bring serious harm to the insurance industry and its image. 
 
One of the commercial insurance industry representatives expressed that even though the 
Insurance Regulatory Commission is pushing for this new benefit to be implemented, the final say 
might still rest with local government, since catastrophic health insurance will be financed by funds 


































Interpreting the Guidance Regarding Implementation of Catastrophic Health Insurance for Urban 
and Rural Residents 
 
The previous articles talked about the Guidance regarding Implementation of Catastrophic Health 
Insurance for Urban and Rural Residents” (Referred to as “Guidance” from now on). What 
constitutes “serious illness”? How much could be covered by insurance? What is the range of 
reimbursement? Deputy Director of the National Development and Reform Commission, Director of 
the Medical Reform Office of the State Council, Zhigang Sun, answered these questions at a recent 
meeting.  
 
For serious illness: the Guidance referenced the World Health Organization’s definition for 
“disastrous medical expense”: if a family’s mandatory medical expenses equal to or greater than 
40% of their discretionary expenses (total income minus basic living expenses). Once a family suffers 
disastrous medical expense, that family could become poor or return to poverty due to illness. Using 
2011 figures, this “disastrous medical expense” is approximately the annual per capital discretionary 
expense for urban residents and per capita annual net income for rural residents.  
 
For reimbursement: patients with serious illness will be paid through their basic insurance first. After 
that, 50% or higher of the reasonable medical expenses will be paid through this new benefit. The 
reimbursement rate is proportional to the total expenses: the higher the cost, the higher the 
reimbursement rate. For the insured under the New Rural Cooperative Medical Insurance and the 





basic health insurance plan, and 50% of their out-of-pocket costs will be paid through the new 
benefit.  
 
For treatment or drugs not covered by current insurance policies: even if the insured received 
treatments or used drugs outside the insurance plans’ list, as long as the expenses are reasonable, 
the insured can be reimbursed. The Guidance is a framework; specific situations will be dealt at the 
local level.  
 
 
  
